Paclitaxel-loaded polyester nanoparticles prepared by spray-drying technology: in vitro bioactivity evaluation

References

• Alexis F, Rhee JW, Richie JP, Radovic-Moreno AF, Langer R, Farokhzad OC. New frontiers in nanotechnology for cancer treatment. Urol Oncol 2008; 26(1)74–85
   PubMed Web of Science ®Google Scholar
• Anderson JM, Shive MS. Biodegradation and biocompatibility of PLA and PLGA microspheres. Adv Drug Delivery Rev 1997; 28: 5–24
   PubMed Web of Science ®Google Scholar
• Bain DF, Munday DL, Smith A. Modulation of rifampicin release from spray-dried microspheres using combinations of poly-(DL-lactide). J Microencapsulation 1999a; 16: 369–85
   PubMed Web of Science ®Google Scholar
• Bain DF, Munday DL, Smith A. Solvent influence on spray-dried biodegradable microspheres. J Microencapsulation 1999b; 16: 453–74
   PubMed Web of Science ®Google Scholar
• Baras B, Benoit M A, Gillard J. Influence of various technological parameters on the preparation of spray-dried poly(ε-caprolactone) microspheres containing a model antigen. J Microencapsulation 2000; 17: 485–98
   PubMed Web of Science ®Google Scholar
• Bartoli MH, Boitard M, Fessi H, Beriel H, Devissaguet JP, Picot F, Puisieux F. In vitro and in vivo antitumoral activity of free, and encapsulated taxol. J Microencapsulation 1990; 7(2)191–7
   PubMed Web of Science ®Google Scholar
• Benoit MA, Baras B, Gillard J. Preparation and characterization of protein-loaded poly(ε-caprolactone) microparticles for oral vaccine delivery. Int J Pharm 1999; 184: 73–84
   PubMed Web of Science ®Google Scholar
• Bilensoy E, Gürkaynak O, Ertan M, Sen M, Hincal AA. Development of nonsurfactant cyclodextrin nanoparticles loaded with anticancer drug paclitaxel. J Pharm Sci 2008; 97(4)1519–29
   PubMed Web of Science ®Google Scholar
• Blanco MD, Bernardo MV, Sastre RL, Olmo R, Muñiz E, Teijón JM. Preparation of bupivacaine-loaded poly(ε-caprolactone) microspheres by spray drying: Drug release studies and biocompatibility. European J Pharm Biopharm 2003; 55(2)229–36
   PubMed Web of Science ®Google Scholar
• Blanco MD, Guerrero S, Teijón C, Olmo R, Pastrana L, Katime I, Teijón JM. Preparation and characterization of nanoparticulate poly (N-isopropylacryl- amide) hydrogel for the controlled release of anti-tumour drugs. Polym Int 2008; 57(11)1215–25
   Web of Science ®Google Scholar
• Blanco MD, Sastre RL, Teijón C, Olmo R, Teijón JM. 5-Fluorouracil-loaded microspheres prepared by spray-drying poly(d,l-lactide) and poly(lactide-co-glycolide) polymers: Characterization and drug release. J Microencapsulation 2005; 22(6)671–82
   PubMed Web of Science ®Google Scholar
• Blanco MD, Sastre RL, Teijón C, Olmo R, Teijón JM. Degradation behaviour of microspheres prepared by spray-drying poly(D,L-lactide) and poly(D,L-lactide-co-glycolide) polymers. Int J Pharm 2006; 326(1–2)139–47
   PubMedGoogle Scholar
• Blanco-Príeto MJ, Besseghir K, Orsolini P, Heimgartner F, Deuschel C, Hans P. Merkle, Nam-Trân H, Gander B. Importance of the test medium for the release kinetics of a somatostatin analogue from poly(D,L-lactide-co-glycolide) microspheres. Int J Pharm 1999; 184(2)243–50
   PubMedGoogle Scholar
• Bouquet W, Ceelen W, Fritzinger B, Pattyn P, Peeters M, Remon JP, Vervaet C. Paclitaxel/beta-cyclodextrin complexes for hyperthermic peritoneal perfusion – formulation and stability. Eur J Pharm Biopharm 2007; 66(3)391–7
   PubMed Web of Science ®Google Scholar
• Brazel CS, Peppas NA. Modeling of drug release from Swellable polymers. European J Pharm Biopharm 2000; 49(1)47–58
   PubMed Web of Science ®Google Scholar
• Cho K, Wang X, Nie S, Chen Z, Shin DM. Therapeutic nanoparticles for drug delivery in cancer. Clin Cancer Res 2008; 14(5)1310–16
   PubMed Web of Science ®Google Scholar
• Danhier F, Lecouturier N, Vroman B, Jérôme C, Marchand-Brynaert J, Feron O, Préat V. Paclitaxel-loaded PEGylated PLGA-based nanoparticles: In vitro and in vivo evaluation. J Controlled Release 2009; 133(1)11–17
   PubMed Web of Science ®Google Scholar
• D’Antone S, Bignotti F, Sartore L, D’Amore A, Spagnoli G, Penco M. Thermogravimetric investigation of two classes of block copolymers based on poly(lactic-glycolic acid) and poly(ε-caprolactone) or poly(ethylene glycol). Polym Degrad Stab 2001; 74(1)119–24
   Web of Science ®Google Scholar
• Ding L, Lee T, Wang CH. Fabrication of monodispersed Taxol-loaded particles using electrohydrodynamic atomization. J Controlled Release 2005; 102: 395–413
   PubMed Web of Science ®Google Scholar
• Dong YY, Feng SS. Poly(d,l-lactide-co-glycolide) (PLGA) nanoparticles prepared by high pressure homogenization for paclitaxel chemotherapy. Int J Pharm 2007; 342: 208–14
   PubMed Web of Science ®Google Scholar
• Dorr RT. Pharmacology and toxicology of Cremophor EL diluent. Ann Pharmaco 1994; 28: 11–14
   PubMed Web of Science ®Google Scholar
• du Bois A, Pfisterer J. Future options for first-line therapy of advanced ovarian cancer. Int J Gynec Cancer 2005; 15: 42–50
   PubMed Web of Science ®Google Scholar
• Dziadyk JM, Sui M, Zhu X, Fan W. Paclitaxel-induced apoptosis may occur without a prior G2/M-phase arrest. Anticancer Res 2004; 24(1)27–36
   PubMed Web of Science ®Google Scholar
• Ei-Arini SK, Leuenberger H. Modelling of drug release from polymer matrices: Effect of drug loading. Int J Pharm 1995; 121(2)141–8
   Google Scholar
• Fetterly GJ, Robert M, Straubinger RM. Pharmacokinetics of Paclitaxel-Containing Liposomes in Rats. AAPS J 2003; 5(4)90–100
   Google Scholar
• Freiberg S, Zhu X. Polymer microspheres for controlled drug release. Int J Pharm 2004; 282: 1–18
   PubMed Web of Science ®Google Scholar
• Fu YJ, Mi FL, Wong TB, Shyn SS. Characteristics and controlled release of anticancer drug loaded poly (D,L lactide) microparticles prepared by spray drying technique. J Microencapsulation 2001; 18: 733–47
   PubMed Web of Science ®Google Scholar
• Guerrero S, Muniz E, Teijón C, Olmo R, Teijón JM, Blanco MD. Ketotifen-loaded microspheres prepared by spray-dryingpoly(D,L-lactide) and poly(D,L-lactide-co-glycolide) polymers: Characterization and in vivo evaluation. J Pharm Sci 2008; 97(8)3153–69
   PubMed Web of Science ®Google Scholar
• Haley B, Frenkel E. Nanoparticles for drug delivery in cancer treatment. Urol Oncol 2008; 26(1)57–64
   PubMed Web of Science ®Google Scholar
• Hawkins MJ, Soon-Shiong P, Desai N. Protein nanoparticles as drug carriers in clinical medicine. Adv Drug Deliv Rev 2008; 60(8)876–85
   PubMed Web of Science ®Google Scholar
• Hiljanen-Vainio M, Karjalainen T, Seppälä J. Biodegradable lactone copolymers. I. Characterization and mechanical behavior of ε-caprolactone and lactide copolymers. J Appl Polym Sci 1996; 59(89)1281–8
   Google Scholar
• Hu FX, Neoh KG, Kang ET. Synthesis and in vitro anti-cancer evaluation of tamoxifen-loaded magnetite/PLLA composite nanoparticles. Biomaterials 2006; 27(33)5725–33
   PubMed Web of Science ®Google Scholar
• Hureaux J, Lagarce F, Gagnadoux F, Clavreul A, Benoit JP, Urban T. The adaptation of lipid nanocapsule formulations for blood administration in animals. Int J Pharm 2009; 379: 266–9
   PubMed Web of Science ®Google Scholar
• Jänicke RU. MCF-7 breast carcinoma cells do not express caspase-3. Breast Cancer Res Treat 2009; 117: 219–21
   PubMed Web of Science ®Google Scholar
• Jin C, Bai L, Wu H, Song W, Guo G, Dou K. Cytotoxicity of paclitaxel incorporated in PLGA nanoparticles on hypoxic human tumor cells. Pharm Res 2009; 26(7)1776–84
   PubMed Web of Science ®Google Scholar
• Jin C, Wu H, Liu J, Bai L, Guo G. The effect of paclitaxel-loaded nanoparticles with radiation on hypoxic MCF-7 cells. J Clin Pharm Ther 2007; 32: 41–47
   PubMed Web of Science ®Google Scholar
• Jones E. Methylene chloride, an overview of human and environmental effects. Pharm Technol Eur 1996; 18: 30–2
   Google Scholar
• Jordan MA, Toso RJ, Thrower D, Wilson L. Mechanism of mitotic block and inhibition of cell proliferation by Taxol at low concentrations. Proc Natl Acad Sci USA 1993; 90: 9552–6
   PubMed Web of Science ®Google Scholar
• Korsmeyer RW, Gurny R, Doelker E, Buri P, Peppas NA. Mechanisms of solute release from porous hydrophilic polymers. Int J Pharm 1983; 15(1)25–35
   Web of Science ®Google Scholar
• Liggins RT, Hunter WL, Burt HM. Solid-state characterization of paclitaxel. J Pharm Sci 1997; 86(12)1458–63
   PubMed Web of Science ®Google Scholar
• Limé F, Irgun K. Monodisperse polymeric particles by photoinitiated precipitation polymerization. Macromolecules 2007; 40: 1962–8
   Web of Science ®Google Scholar
• Liu J, Chew C, Gan L, Teo W, Gan L. Synthesis of monodisperse polystyrene microlatexes by emulsion polymerization using a polymerizable surfactant. Langmuir 1997; 13: 4988–94
   Web of Science ®Google Scholar
• Liu J, Meisner D, Kwong E, Wu XY, Johnston MR. A novel trans-lymphatic drug delivery system: Implantable gelatin sponge impregnated with PLGA-paclitaxel microspheres. Biomaterials 2007; 28: 3236–44
   PubMed Web of Science ®Google Scholar
• Long BH, Fairchild CR. Paclitaxel inhibits progression of mitotic cells to G1 phase by interference with spindle formation without affecting other microtubule functions during anaphase and telophase. Cancer Res 1994; 54: 4355–61
   PubMed Web of Science ®Google Scholar
• Maeda H, Wu J, Sawa T, Matsumura Y, Hori K. Tumor vascular permeability and the EPR effect in macromolecular therapeutics. J Controlled Release 2000; 65(1–2)271–84
   PubMed Web of Science ®Google Scholar
• Mei L, Zhang Y, Zheng Y, Tian G, Song C, Yang D, Chen H, Sun H, Tian Y, Liu K, et al. A novel docetaxel-loaded poly (e-caprolactone)/pluronic f68 nanoparticle overcoming multidrug resistance for breast cancer treatment. Nanoscale Res Lett 2009; 4: 1530–9
   PubMed Web of Science ®Google Scholar
• Michalides R, Tiemessen M, Verschoor T, Balkenende A, Coco-Martin J. Overexpression of cyclin D1 enhances taxol induced mitotic death in MCF7 cells. Breast Cancer Res Treat 2002; 74: 55–63
   PubMed Web of Science ®Google Scholar
• Mu L, Feng SS. Fabrication, characterization and in vitro release of paclitaxel (Taxol®) loaded poly (lactic-co-glycolic acid) microspheres prepared by spray drying technique with lipid/cholesterol emulsifiers. J Controlled Release 2001; 76: 239–54
   PubMed Web of Science ®Google Scholar
• Murillo M, Gamazo C, Goñi MM, Irache JM, Blanco-Príeto MJ. Development of microparticles prepared by spray-drying as a vaccine delivery system against brucellosis. Int J Pharm 2002; 242(1–2)341–4
   PubMedGoogle Scholar
• Nakanishi Y, Cutitta F, Kasprzyk PG, Avis I, Steinberg SM, Gazdar AF, Mulshine JL. Growth factor effects on small cell lung cancer cells using a colorimetric assay: Can a tranferrin-like factor mediate autocrine growth. Exp Cell Biol 1988; 56: 74–85
   PubMedGoogle Scholar
• Onyuksel AH, Ramakrishnan S, Chai HB, Pezzuto JM. A mixed micellar formulation suitable for the parenteral administration of taxol. Pharm Res 1994; 11(2)206–12
   PubMed Web of Science ®Google Scholar
• Penco M, Sartore L, Bignotti F, D’Antone S, Di Landro L. Thermal properties of a new class of block copolymers based on segments of poly(D,L-lactic-glycolic acid) and poly(ε-caprolactone). Eur Polym J 2000; 36(5)901–8
   Web of Science ®Google Scholar
• Ritger PL, Peppas NA. A simple equation for description of solute release II. Fickian and anomalous release from swellable devices. J Controlled Release 1987; 5(1)37–42
   Google Scholar
• Rowinsky EK, Cazenave LA, Donehower RC. Taxol: A novel investigational antimicrotubule agent. J Natl Cancer Inst 1990; 82 (15)1247–59
   PubMed Web of Science ®Google Scholar
• Safra T, Menczer J, Bernstein RM, Shpigel S, Matcejevsky D, Inbar MJ, Golan A, Grisaru D, Levy T. Combined weekly carboplatin and paclitaxel as primary treatment of advanced epithelial ovarian carcinoma. Gynec Oncol 2009; 114(2)215–8
   PubMed Web of Science ®Google Scholar
• Sastre RL, Blanco MD, Teijón C, Olmo R, Teijón JM. Preparation and characterization of 5-fluorouracil-loaded poly(ε-caprolactone) microspheres for drug administration. Drug Dev Res 2004; 63(2)41–53
   Web of Science ®Google Scholar
• Schiff PB, Horwitz SB. Taxol stabilizes microtubules in mouse fibroblast cells. Proc Natl Acad Sci USA 1980; 77: 1561–5
   PubMed Web of Science ®Google Scholar
• Serrano MC, Pagani R, Vallet-Regí M, Peña J, Rámila A, Izquierdo I, Portolés MT. In vitro biocompatibility assessment of poly(ε-caprolactone) films using L929 mouse fibroblasts. Biomaterials 2004; 25(25)5603–11
   PubMed Web of Science ®Google Scholar
• Sharma A, Straubinger RM. Novel taxol formulations: Preparation and characterization of taxol-containing liposomes. Pharm Res 1994; 11(6)889–96
   PubMed Web of Science ®Google Scholar
• Shi GX, Cai Q, Wang CY, Lu N, Wang SG, Bei JZ. Fabrication and biocompatibility of cell scaffolds of poly(L-lactic acid) and poly(L-lactic-co-glycolic acid). Polym Adv Technol 2002; 13: 227–32
   Web of Science ®Google Scholar
• Siepmann J, Faisant N, Akiki J, Richard J, Benoit JP. Effect of the size of biodegradable microparticles on drug release: Experiment and theory. J Controlled Release 2004; 96: 123–34
   PubMed Web of Science ®Google Scholar
• Siepmann J, Siepmann F. Mathematical modeling of drug delivery. International J Pharm 2008; 364(2)328–43
   PubMed Web of Science ®Google Scholar
• Silva-Júnior AA, Scarpa MV, Pestana KC, Mercuri LP, de Matos JR, Gomes de OliveiraThermal A. Analysis of biodegradable microparticles containing ciprofloxacin hydrochloride obtained by spray drying technique. Thermochim Acta 2008; 467(1–2)91–8
   Web of Science ®Google Scholar
• Teneriello MG, Tseng PC, Crozier M, Encarnacion C, Hancock K, Messing MJ, Boehm KA, Williams A, Asmar L. Phase II evaluation of nanoparticle albumin-bound paclitaxel in platinum-sensitive patients with recurrent ovarian, peritoneal, or fallopian tube cancer. J Clin Oncol 2009; 27(9)1426–31
   PubMed Web of Science ®Google Scholar
• Thomadaki H, Talieri M, Scorilas A. Treatment of MCF-7 cells with Taxol and etoposide induces distinct alterations in the expression of apoptosis-related genes BCL2, BCL2L12, BAX, CASPASE-9 and FAS. Biol Chem 2006; 387: 1081–6
   PubMed Web of Science ®Google Scholar
• Wang FJ, Wang CH. Etanidazole-loaded microspheres fabricated by spray-drying different poly(lactide/glycolide) polymers: Effects on microsphere properties. J Biomater Sci 2003; 14: 157–83
   PubMed Web of Science ®Google Scholar
• Webster L, Linsenmeyer M, Millward M, Morton C, Bishop J, Woodcock D. Measurement of Cremophor EL following taxol: Plasma levels sufficient to reverse drug exclusion mediated by the multidrug-resistant phenotype. J Nat Cancer Inst 1993; 85: 1685–90
   PubMed Web of Science ®Google Scholar
• Yang T, Cui FD, Choi MK, Cho JW, Chung SJ, Shim CK, Kim DD. Enhanced solubility and stability of PEGylated liposomal paclitaxel: In vitro and in vivo evaluation. Int J Pharm 2007; 338(1–2)317–26
   PubMed Web of Science ®Google Scholar
• Yang H, Sladek TL, Liu X, Butler BR, Froelich CJ, Thor AD. Reconstitution of caspase 3 sensitizes MCF-7 breast cancer cells to doxorubicin- and etoposide-induced apoptosis. Cancer res 2001; 61(1)348–54
   PubMed Web of Science ®Google Scholar
• Yeung TK, Germond C, Chen X, Wang Z. The mode of action of taxol: Apoptosis at low concentration and necrosis at high concentration. Biochem Biophys Res Commun 1999; 263: 398–404
   PubMed Web of Science ®Google Scholar
• Zhang Z, Feng SS. The drug encapsulation efficiency, in vitro drug release, cellular uptake and cytotoxicity of paclitaxel-loaded poly(lactide)-tocopheryl polyethylene glycol succinate nanoparticles. Biomater 2006; 27(21)4025–33
   PubMed Web of Science ®Google Scholar
• Zhang Z, Lee SH, Gan CW, Feng SS. In vitro and in vivo investigation on PLA–TPGS nanoparticles for controlled and sustained small molecule chemotherapy. Pharm Res 2008; 25(8)1925–35
   PubMed Web of Science ®Google Scholar